ZOE SCHULTZ: Open Payments
NPI 1093140659 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 28 payments from 10 companies in 2025. Trend: 2023 $1,521 · 2024 $1,547 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $143 |
| Astellas Pharma US Inc | 5 | $104 |
| Corium, LLC | 5 | $93 |
| Globus Medical, Inc. | 2 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Abbott Laboratories | 2 | $38 |
| ABBVIE INC. | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: Qelbree, Veozah, Azstarys, Senza, Jornay PM, UBRELVY, ZEPBOUND, TZIELD.
Industry payments across GA — which companies pay providers there.
